Sept 26 (Reuters) - Cereno Scientific AB CRNOSb.TE :
* CERENO SCIENTIFIC RECEIVES APPROVAL FOR THE START OF A
PHASE II
CLINICAL TRIAL IN RUSSIA
* COMPANY INTENDS TO START STUDY FIRST HALF OF 2020 WITH
INTENTION
OF DEMONSTRATING CS1'S PREVENTATIVE EFFECT AGAINST FORMATION OF
BLOOD CLOTS AFTER ORTHOPEDIC SURGERY
* IN MAY, CERENO SCIENTIFIC ALSO SUBMITTED AN APPLICATION TO
START
STUDY WITH CS1 TO AUTHORITIES IN BULGARIA
* CERENO SCIENTIFIC EXPECTS APPROVAL FOR PHASE II STUDY BY
BULGARIAN AUTHORITIES THIS FALL
Source text for Eikon: ID:nWkr324pSP
Further company coverage: CRNOSb.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com;))